Zydus Lifesciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS LIFESCIENCES, and what generic alternatives to ZYDUS LIFESCIENCES drugs are available?
ZYDUS LIFESCIENCES has sixty-seven approved drugs.
There is one US patent protecting ZYDUS LIFESCIENCES drugs.
There are four patent family members on ZYDUS LIFESCIENCES drugs in four countries and one hundred and sixty-two supplementary protection certificates in sixteen countries.
Summary for Zydus Lifesciences
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 58 |
| Ingredients: | 58 |
| NDAs: | 67 |
Drugs and US Patents for Zydus Lifesciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | DOXYCYCLINE HYCLATE | doxycycline hyclate | CAPSULE;ORAL | 207774-002 | May 31, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus Lifesciences | DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) | doxorubicin hydrochloride | INJECTABLE, LIPOSOMAL;INJECTION | 212299-002 | Sep 10, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus Lifesciences | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077625-001 | Oct 16, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus Lifesciences | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 207764-001 | Nov 8, 2018 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Zydus Lifesciences Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| India | 651MU2014 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2015128877 | ⤷ Try a Trial |
| South Africa | 201606075 | ⤷ Try a Trial |
| Philippines | 12016501686 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zydus Lifesciences Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0206283 | 98C0041 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606 |
| 0459136 | SPC/GB97/018 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: CANDESARTAN CILEXETIL OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: UK PL0017/0383 19970429; UK PL0017/0384 19970429; UK PL0017/0385 19970429; UK PL0017/0391 19970429; UK PL15561/0003 19970429; UK PL15661/0001 19970429; UK PL15661/0002 19970429; UK PL15661/0004 19970429 |
| 1412357 | 122007000056 | Germany | ⤷ Try a Trial | PRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE FUER SITAGLIPTINPHOSPHAT-MONOHYDRAT; REGISTRATION NO/DATE: EU/1/07/383/001-018 20070321 |
| 1532149 | 92128 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3, 7-DIHYDROPURIN-2, 6-DION, LES ENANTIOMERES ET LEURS SELS, EN PARTICULIER LA LINAGLIPTINE COMBINEE AVEC DU CHLORHYDRATE DE METFORMINE. LINAGLIPTINE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
